0001213900-24-025519.txt : 20240325 0001213900-24-025519.hdr.sgml : 20240325 20240325160133 ACCESSION NUMBER: 0001213900-24-025519 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230829 FILED AS OF DATE: 20240325 DATE AS OF CHANGE: 20240325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Louria Hayon Igal CENTRAL INDEX KEY: 0001903781 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53002 FILM NUMBER: 24779142 MAIL ADDRESS: STREET 1: 4 LUI PASTER CITY: TEL AVIV-JAFFA STATE: L3 ZIP: 6803605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Raphael Pharmaceutical Inc. CENTRAL INDEX KEY: 0001415397 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 260204284 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 105 - 5348 VEGAS DR. CITY: LAS VEGAS STATE: NV ZIP: 89108 BUSINESS PHONE: 702-442-1166 MAIL ADDRESS: STREET 1: SUITE 105 - 5348 VEGAS DR. CITY: LAS VEGAS STATE: NV ZIP: 89108 FORMER COMPANY: FORMER CONFORMED NAME: Easy Energy Inc DATE OF NAME CHANGE: 20071017 4 1 ownership.xml X0508 4 2023-08-29 0 0001415397 Raphael Pharmaceutical Inc. RAPH 0001903781 Louria Hayon Igal 4 LUI PASTER TEL AVIV-JAFFA L3 6803605 ISRAEL 1 1 0 0 Chief Technology Officer 0 Common Stock 2023-08-29 4 X 0 999000 0.01 A 999000 D Warrants to purchase Common Stock 0.01 2023-08-29 2023-08-29 4 X 0 999000 D 2022-12-05 2024-07-05 Common Stock 999000 0 D The transaction reported is an exercise of warrants to purchase common stock. In accordance with General Instruction 4(c)(iii), the exercise price is reported under column 2 of this table. /s/ Igal Louria Hayon 2024-03-25